APO Research
Talk to an analyst

APO RESEARCH · REPORT

Long-acting Insulin Injection

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Long-acting Insulin Injection Industry Growth and Trends Forecast to 2032

23 December 2025118 pages

Choose your research edition.

Industry ResearchLong-acting Insulin Injection Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Long-acting Insulin Injection Industry Growth and Trends Forecast to 2032118 pages · $3,450 USDMarket StructureGlobal Long-acting Insulin Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Long-acting Insulin Injection Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Long-acting Insulin Injection Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global Long-acting Insulin Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Long-acting Insulin Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Long-acting Insulin Injection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Long-acting Insulin Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Long-acting Insulin Injection include United Laboratories, Tonghua Dongbao, Sanofi, Novo Nordisk, Eli Lilly & Co, Gan & Lee, Wockhardt, Viatris and Swixx Biopharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Long-acting Insulin Injection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Long-acting Insulin Injection market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Long-acting Insulin Injection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Long-acting Insulin Injection.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Long-acting Insulin Injection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Long-acting Insulin Injection Market by Company

United Laboratories

Tonghua Dongbao

Sanofi

Novo Nordisk

Eli Lilly & Co

Gan & Lee

Wockhardt

Viatris

Swixx Biopharma

Lupin Laboratories

KALBE PHARMA

INFION PHARMA

Cipla

Biocon Biologics

Biocare

Abbott Laboratories

Long-acting Insulin Injection Segment by Type

Insulin Glargine

Insulin Detemir

Insulin Degludec

Long-acting Insulin Injection Segment by Application

Type 1 Diabetes

Type 2 Diabetes

Long-acting Insulin Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Long-acting Insulin Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Long-acting Insulin Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Long-acting Insulin Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Long-acting Insulin Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Long-acting Insulin Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Insulin Glargine Table 2. Major Company of Insulin Detemir Table 3. Major Company of Insulin Degludec Table 4. Global Long-acting Insulin Injection Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Long-acting Insulin Injection Sales by Type (2021-2026) & (k units) Table 6. Global Long-acting Insulin Injection Sales Market Share in Volume by Type (2021-2026) Table 7. Global Long-acting Insulin Injection Sales by Type (2021-2026) & (US$ Million) Table 8. Global Long-acting Insulin Injection Sales Market Share in Value by Type (2021-2026) Table 9. Global Long-acting Insulin Injection Price by Type (2021-2026) & (USD/unit) Table 10. Global Long-acting Insulin Injection Sales by Type (2027-2032) & (k units) Table 11. Global Long-acting Insulin Injection Sales Market Share in Volume by Type (2027-2032) Table 12. Global Long-acting Insulin Injection Sales by Type (2027-2032) & (US$ Million) Table 13. Global Long-acting Insulin Injection Sales Market Share in Value by Type (2027-2032) Table 14. Global Long-acting Insulin Injection Price by Type (2027-2032) & (USD/unit) Table 15. North America Long-acting Insulin Injection Sales by Type (2021-2026) & (k units) Table 16. North America Long-acting Insulin Injection Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Long-acting Insulin Injection Sales by Type (2021-2026) & (k units) Table 18. Europe Long-acting Insulin Injection Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Long-acting Insulin Injection Sales by Type (2021-2026) & (k units) Table 20. Asia-Pacific Long-acting Insulin Injection Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Long-acting Insulin Injection Sales by Type (2021-2026) & (k units) Table 22. Latin America Long-acting Insulin Injection Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Long-acting Insulin Injection Sales by Type (2021-2026) & (k units) Table 24. Middle East and Africa Long-acting Insulin Injection Sales by Type (2021-2026) & (US$ Million) Table 25. Long-acting Insulin Injection Industry Trends Table 26. Long-acting Insulin Injection Industry Drivers Table 27. Long-acting Insulin Injection Industry Opportunities and Challenges Table 28. Long-acting Insulin Injection Industry Restraints Table 29. Global Long-acting Insulin Injection Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Long-acting Insulin Injection Revenue Market Share by Company (2021-2026) Table 31. Global Long-acting Insulin Injection Sales by Company (2021-2026) & (k units) Table 32. Global Long-acting Insulin Injection Sales Share by Company (2021-2026) Table 33. Global Long-acting Insulin Injection Market Price by Company (2021-2026) & (USD/unit) Table 34. Global Long-acting Insulin Injection Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Long-acting Insulin Injection Major Company Production Sites and Headquarters Table 36. Global Long-acting Insulin Injection Company, Product Type & Application Table 37. Global Long-acting Insulin Injection Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Long-acting Insulin Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Long-acting Insulin Injection Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Long-acting Insulin Injection Sales by Region (2021-2026) & (k units) Table 42. Global Long-acting Insulin Injection Sales Market Share in Volume by Region (2021-2026) Table 43. Global Long-acting Insulin Injection Sales by Region (2021-2026) & (US$ Million) Table 44. Global Long-acting Insulin Injection Sales Market Share in Value by Region (2021-2026) Table 45. Global Long-acting Insulin Injection Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 46. Global Long-acting Insulin Injection Sales by Region (2027-2032) & (k units) Table 47. Global Long-acting Insulin Injection Sales Market Share in Volume by Region (2027-2032) Table 48. Global Long-acting Insulin Injection Sales by Region (2027-2032) & (US$ Million) Table 49. Global Long-acting Insulin Injection Sales Market Share in Value by Region (2027-2032) Table 50. Global Long-acting Insulin Injection Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2027-2032) Table 51. Global Long-acting Insulin Injection Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Long-acting Insulin Injection Sales by Application (2021-2026) & (k units) Table 53. Global Long-acting Insulin Injection Sales Market Share in Volume by Application (2021-2026) Table 54. Global Long-acting Insulin Injection Sales by Application (2021-2026) & (US$ Million) Table 55. Global Long-acting Insulin Injection Sales Market Share in Value by Application (2021-2026) Table 56. Global Long-acting Insulin Injection Price by Application (2021-2026) & (USD/unit) Table 57. Global Long-acting Insulin Injection Sales by Application (2027-2032) & (k units) Table 58. Global Long-acting Insulin Injection Sales Market Share in Volume by Application (2027-2032) Table 59. Global Long-acting Insulin Injection Sales by Application (2027-2032) & (US$ Million) Table 60. Global Long-acting Insulin Injection Sales Market Share in Value by Application (2027-2032) Table 61. Global Long-acting Insulin Injection Price by Application (2027-2032) & (USD/unit) Table 62. North America Long-acting Insulin Injection Sales by Application (2021-2026) & (k units) Table 63. North America Long-acting Insulin Injection Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Long-acting Insulin Injection Sales by Application (2021-2026) & (k units) Table 65. Europe Long-acting Insulin Injection Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Long-acting Insulin Injection Sales by Application (2021-2026) & (k units) Table 67. Asia-Pacific Long-acting Insulin Injection Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Long-acting Insulin Injection Sales by Application (2021-2026) & (k units) Table 69. Latin America Long-acting Insulin Injection Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Long-acting Insulin Injection Sales by Application (2021-2026) & (k units) Table 71. Middle East and Africa Long-acting Insulin Injection Sales by Application (2021-2026) & (US$ Million) Table 72. United Laboratories Company Information Table 73. United Laboratories Business Overview Table 74. United Laboratories Long-acting Insulin Injection Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 75. United Laboratories Long-acting Insulin Injection Product Portfolio Table 76. United Laboratories Recent Development Table 77. Tonghua Dongbao Company Information Table 78. Tonghua Dongbao Business Overview Table 79. Tonghua Dongbao Long-acting Insulin Injection Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 80. Tonghua Dongbao Long-acting Insulin Injection Product Portfolio Table 81. Tonghua Dongbao Recent Development Table 82. Sanofi Company Information Table 83. Sanofi Business Overview Table 84. Sanofi Long-acting Insulin Injection Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 85. Sanofi Long-acting Insulin Injection Product Portfolio Table 86. Sanofi Recent Development Table 87. Novo Nordisk Company Information Table 88. Novo Nordisk Business Overview Table 89. Novo Nordisk Long-acting Insulin Injection Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 90. Novo Nordisk Long-acting Insulin Injection Product Portfolio Table 91. Novo Nordisk Recent Development Table 92. Eli Lilly & Co Company Information Table 93. Eli Lilly & Co Business Overview Table 94. Eli Lilly & Co Long-acting Insulin Injection Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Eli Lilly & Co Long-acting Insulin Injection Product Portfolio Table 96. Eli Lilly & Co Recent Development Table 97. Gan & Lee Company Information Table 98. Gan & Lee Business Overview Table 99. Gan & Lee Long-acting Insulin Injection Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. Gan & Lee Long-acting Insulin Injection Product Portfolio Table 101. Gan & Lee Recent Development Table 102. Wockhardt Company Information Table 103. Wockhardt Business Overview Table 104. Wockhardt Long-acting Insulin Injection Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. Wockhardt Long-acting Insulin Injection Product Portfolio Table 106. Wockhardt Recent Development Table 107. Viatris Company Information Table 108. Viatris Business Overview Table 109. Viatris Long-acting Insulin Injection Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. Viatris Long-acting Insulin Injection Product Portfolio Table 111. Viatris Recent Development Table 112. Swixx Biopharma Company Information Table 113. Swixx Biopharma Business Overview Table 114. Swixx Biopharma Long-acting Insulin Injection Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. Swixx Biopharma Long-acting Insulin Injection Product Portfolio Table 116. Swixx Biopharma Recent Development Table 117. Lupin Laboratories Company Information Table 118. Lupin Laboratories Business Overview Table 119. Lupin Laboratories Long-acting Insulin Injection Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 120. Lupin Laboratories Long-acting Insulin Injection Product Portfolio Table 121. Lupin Laboratories Recent Development Table 122. KALBE PHARMA Company Information Table 123. KALBE PHARMA Business Overview Table 124. KALBE PHARMA Long-acting Insulin Injection Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 125. KALBE PHARMA Long-acting Insulin Injection Product Portfolio Table 126. KALBE PHARMA Recent Development Table 127. INFION PHARMA Company Information Table 128. INFION PHARMA Business Overview Table 129. INFION PHARMA Long-acting Insulin Injection Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 130. INFION PHARMA Long-acting Insulin Injection Product Portfolio Table 131. INFION PHARMA Recent Development Table 132. Cipla Company Information Table 133. Cipla Business Overview Table 134. Cipla Long-acting Insulin Injection Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 135. Cipla Long-acting Insulin Injection Product Portfolio Table 136. Cipla Recent Development Table 137. Biocon Biologics Company Information Table 138. Biocon Biologics Business Overview Table 139. Biocon Biologics Long-acting Insulin Injection Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 140. Biocon Biologics Long-acting Insulin Injection Product Portfolio Table 141. Biocon Biologics Recent Development Table 142. Biocare Company Information Table 143. Biocare Business Overview Table 144. Biocare Long-acting Insulin Injection Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 145. Biocare Long-acting Insulin Injection Product Portfolio Table 146. Biocare Recent Development Table 147. Abbott Laboratories Company Information Table 148. Abbott Laboratories Business Overview Table 149. Abbott Laboratories Long-acting Insulin Injection Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 150. Abbott Laboratories Long-acting Insulin Injection Product Portfolio Table 151. Abbott Laboratories Recent Development Table 152. North America Long-acting Insulin Injection Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 153. North America Long-acting Insulin Injection Sales by Country (2021-2026) & (k units) Table 154. North America Long-acting Insulin Injection Sales Market Share by Country (2021-2026) Table 155. North America Long-acting Insulin Injection Sales Forecast by Country (2027-2032) & (k units) Table 156. North America Long-acting Insulin Injection Sales Market Share Forecast by Country (2027-2032) Table 157. North America Long-acting Insulin Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. North America Long-acting Insulin Injection Market Size by Country (2021-2026) & (US$ Million) Table 159. North America Long-acting Insulin Injection Market Share by Country (2021-2026) Table 160. North America Long-acting Insulin Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. North America Long-acting Insulin Injection Market Share Forecast by Country (2027-2032) Table 162. Europe Long-acting Insulin Injection Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 163. Europe Long-acting Insulin Injection Sales by Country (2021-2026) & (k units) Table 164. Europe Long-acting Insulin Injection Sales Market Share by Country (2021-2026) Table 165. Europe Long-acting Insulin Injection Sales Forecast by Country (2027-2032) & (k units) Table 166. Europe Long-acting Insulin Injection Sales Market Share Forecast by Country (2027-2032) Table 167. Europe Long-acting Insulin Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. Europe Long-acting Insulin Injection Market Size by Country (2021-2026) & (US$ Million) Table 169. Europe Long-acting Insulin Injection Market Share by Country (2021-2026) Table 170. Europe Long-acting Insulin Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. Europe Long-acting Insulin Injection Market Share Forecast by Country (2027-2032) Table 172. Asia-Pacific Long-acting Insulin Injection Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 173. Asia-Pacific Long-acting Insulin Injection Sales by Country (2021-2026) & (k units) Table 174. Asia-Pacific Long-acting Insulin Injection Sales Market Share by Country (2021-2026) Table 175. Asia-Pacific Long-acting Insulin Injection Sales Forecast by Country (2027-2032) & (k units) Table 176. Asia-Pacific Long-acting Insulin Injection Sales Market Share Forecast by Country (2027-2032) Table 177. Asia-Pacific Long-acting Insulin Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 178. Asia-Pacific Long-acting Insulin Injection Market Size by Country (2021-2026) & (US$ Million) Table 179. Asia-Pacific Long-acting Insulin Injection Market Share by Country (2021-2026) Table 180. Asia-Pacific Long-acting Insulin Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 181. Asia-Pacific Long-acting Insulin Injection Market Share Forecast by Country (2027-2032) Table 182. Latin America Long-acting Insulin Injection Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 183. Latin America Long-acting Insulin Injection Sales by Country (2021-2026) & (k units) Table 184. Latin America Long-acting Insulin Injection Sales Market Share by Country (2021-2026) Table 185. Latin America Long-acting Insulin Injection Sales Forecast by Country (2027-2032) & (k units) Table 186. Latin America Long-acting Insulin Injection Sales Market Share Forecast by Country (2027-2032) Table 187. Latin America Long-acting Insulin Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 188. Latin America Long-acting Insulin Injection Market Size by Country (2021-2026) & (US$ Million) Table 189. Latin America Long-acting Insulin Injection Market Share by Country (2021-2026) Table 190. Latin America Long-acting Insulin Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 191. Latin America Long-acting Insulin Injection Market Share Forecast by Country (2027-2032) Table 192. Middle East and Africa Long-acting Insulin Injection Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 193. Middle East and Africa Long-acting Insulin Injection Sales by Country (2021-2026) & (k units) Table 194. Middle East and Africa Long-acting Insulin Injection Sales Market Share by Country (2021-2026) Table 195. Middle East and Africa Long-acting Insulin Injection Sales Forecast by Country (2027-2032) & (k units) Table 196. Middle East and Africa Long-acting Insulin Injection Sales Market Share Forecast by Country (2027-2032) Table 197. Middle East and Africa Long-acting Insulin Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 198. Middle East and Africa Long-acting Insulin Injection Market Size by Country (2021-2026) & (US$ Million) Table 199. Middle East and Africa Long-acting Insulin Injection Market Share by Country (2021-2026) Table 200. Middle East and Africa Long-acting Insulin Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 201. Middle East and Africa Long-acting Insulin Injection Market Share Forecast by Country (2027-2032) Table 202. Key Raw Materials Table 203. Raw Materials Key Suppliers Table 204. Long-acting Insulin Injection Distributors List Table 205. Long-acting Insulin Injection Customers List Table 206. Research Programs/Design for This Report Table 207. Authors List of This Report Table 208. Secondary Sources Table 209. Primary Sources List of Figures Figure 1. Long-acting Insulin Injection Image Figure 2. Global Long-acting Insulin Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Long-acting Insulin Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Long-acting Insulin Injection Sales (2021-2032) & (k units) Figure 5. Insulin Glargine Image Figure 6. Global Insulin Glargine Sales YoY Growth (2021-2032) & (k units) Figure 7. Insulin Detemir Image Figure 8. Global Insulin Detemir Sales YoY Growth (2021-2032) & (k units) Figure 9. Insulin Degludec Image Figure 10. Global Insulin Degludec Sales YoY Growth (2021-2032) & (k units) Figure 11. Global Long-acting Insulin Injection Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Long-acting Insulin Injection Market Share by Type 2025 VS 2032 Figure 13. North America Long-acting Insulin Injection Sales Market Share in Volume by Type in 2025 Figure 14. North America Long-acting Insulin Injection Sales Market Share in Value by Type in 2025 Figure 15. Europe Long-acting Insulin Injection Sales Market Share in Volume by Type in 2025 Figure 16. Europe Long-acting Insulin Injection Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Long-acting Insulin Injection Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Long-acting Insulin Injection Sales Market Share in Value by Type in 2025 Figure 19. Latin America Long-acting Insulin Injection Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Long-acting Insulin Injection Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Long-acting Insulin Injection Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Long-acting Insulin Injection Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Long-acting Insulin Injection Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Type 1 Diabetes Image Figure 26. Global Type 1 Diabetes Sales YoY Growth (2021-2032) & (k units) Figure 27. Type 2 Diabetes Image Figure 28. Global Type 2 Diabetes Sales YoY Growth (2021-2032) & (k units) Figure 29. Global Long-acting Insulin Injection Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Long-acting Insulin Injection Market Share by Application 2025 VS 2032 Figure 31. North America Long-acting Insulin Injection Sales Market Share in Volume by Application in 2025 Figure 32. North America Long-acting Insulin Injection Sales Market Share in Value by Application in 2025 Figure 33. Europe Long-acting Insulin Injection Sales Market Share in Volume by Application in 2025 Figure 34. Europe Long-acting Insulin Injection Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Long-acting Insulin Injection Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Long-acting Insulin Injection Sales Market Share in Value by Application in 2025 Figure 37. Latin America Long-acting Insulin Injection Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Long-acting Insulin Injection Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Long-acting Insulin Injection Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Long-acting Insulin Injection Sales Market Share in Value by Application in 2025 Figure 41. North America Long-acting Insulin Injection Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 42. North America Long-acting Insulin Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Long-acting Insulin Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Long-acting Insulin Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Long-acting Insulin Injection Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. Europe Long-acting Insulin Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Long-acting Insulin Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Long-acting Insulin Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Long-acting Insulin Injection Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Asia-Pacific Long-acting Insulin Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Long-acting Insulin Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Long-acting Insulin Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Long-acting Insulin Injection Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Latin America Long-acting Insulin Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Long-acting Insulin Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Long-acting Insulin Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Long-acting Insulin Injection Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Middle East and Africa Long-acting Insulin Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Long-acting Insulin Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Long-acting Insulin Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Long-acting Insulin Injection Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Long-acting Insulin Injection Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Insulin Glargine
  • Insulin Detemir
  • Insulin Degludec
Applications
  • Type 1 Diabetes
  • Type 2 Diabetes
Companies covered
  • United Laboratories
  • Tonghua Dongbao
  • Sanofi
  • Novo Nordisk
  • Eli Lilly & Co
  • Gan & Lee
  • Wockhardt
  • Viatris
  • Swixx Biopharma
  • Lupin Laboratories
  • KALBE PHARMA
  • INFION PHARMA
  • Cipla
  • Biocon Biologics
  • Biocare
  • Abbott Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Long-acting Insulin Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Long-acting Insulin Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Long-acting Insulin Injection Market by Type
  6. 1.3.1 Insulin Glargine
  7. 1.3.2 Insulin Detemir
  8. 1.3.3 Insulin Degludec
  9. 1.4 Global Long-acting Insulin Injection Market Size by Type
  10. 1.4.1 Global Long-acting Insulin Injection Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Long-acting Insulin Injection Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Long-acting Insulin Injection Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Long-acting Insulin Injection Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Long-acting Insulin Injection Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Long-acting Insulin Injection Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Long-acting Insulin Injection Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Long-acting Insulin Injection Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Long-acting Insulin Injection Industry Trends
  2. 2.2 Long-acting Insulin Injection Industry Drivers
  3. 2.3 Long-acting Insulin Injection Industry Opportunities and Challenges
  4. 2.4 Long-acting Insulin Injection Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Long-acting Insulin Injection Revenue (2021-2026)
  2. 3.2 Global Top Players by Long-acting Insulin Injection Sales (2021-2026)
  3. 3.3 Global Top Players by Long-acting Insulin Injection Price (2021-2026)
  4. 3.4 Global Long-acting Insulin Injection Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Long-acting Insulin Injection Major Company Production Sites & Headquarters
  6. 3.6 Global Long-acting Insulin Injection Company, Product Type & Application
  7. 3.7 Global Long-acting Insulin Injection Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Long-acting Insulin Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Long-acting Insulin Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Long-acting Insulin Injection Tier 1, Tier 2, and Tier 3
4 Long-acting Insulin Injection Regional Status and Outlook
  1. 4.1 Global Long-acting Insulin Injection Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Long-acting Insulin Injection Historic Market Size by Region
  3. 4.2.1 Global Long-acting Insulin Injection Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Long-acting Insulin Injection Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Long-acting Insulin Injection Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Long-acting Insulin Injection Forecasted Market Size by Region
  7. 4.3.1 Global Long-acting Insulin Injection Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Long-acting Insulin Injection Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Long-acting Insulin Injection Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Long-acting Insulin Injection by Application
  1. 5.1 Long-acting Insulin Injection Market by Application
  2. 5.1.1 Type 1 Diabetes
  3. 5.1.2 Type 2 Diabetes
  4. 5.2 Global Long-acting Insulin Injection Market Size by Application
  5. 5.2.1 Global Long-acting Insulin Injection Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Long-acting Insulin Injection Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Long-acting Insulin Injection Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Long-acting Insulin Injection Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Long-acting Insulin Injection Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Long-acting Insulin Injection Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Long-acting Insulin Injection Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Long-acting Insulin Injection Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 United Laboratories
  2. 6.1.1 United Laboratories Company Information
  3. 6.1.2 United Laboratories Business Overview
  4. 6.1.3 United Laboratories Long-acting Insulin Injection Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 United Laboratories Long-acting Insulin Injection Product Portfolio
  6. 6.1.5 United Laboratories Recent Developments
  7. 6.2 Tonghua Dongbao
  8. 6.2.1 Tonghua Dongbao Company Information
  9. 6.2.2 Tonghua Dongbao Business Overview
  10. 6.2.3 Tonghua Dongbao Long-acting Insulin Injection Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Tonghua Dongbao Long-acting Insulin Injection Product Portfolio
  12. 6.2.5 Tonghua Dongbao Recent Developments
  13. 6.3 Sanofi
  14. 6.3.1 Sanofi Company Information
  15. 6.3.2 Sanofi Business Overview
  16. 6.3.3 Sanofi Long-acting Insulin Injection Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Sanofi Long-acting Insulin Injection Product Portfolio
  18. 6.3.5 Sanofi Recent Developments
  19. 6.4 Novo Nordisk
  20. 6.4.1 Novo Nordisk Company Information
  21. 6.4.2 Novo Nordisk Business Overview
  22. 6.4.3 Novo Nordisk Long-acting Insulin Injection Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Novo Nordisk Long-acting Insulin Injection Product Portfolio
  24. 6.4.5 Novo Nordisk Recent Developments
  25. 6.5 Eli Lilly & Co
  26. 6.5.1 Eli Lilly & Co Company Information
  27. 6.5.2 Eli Lilly & Co Business Overview
  28. 6.5.3 Eli Lilly & Co Long-acting Insulin Injection Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Eli Lilly & Co Long-acting Insulin Injection Product Portfolio
  30. 6.5.5 Eli Lilly & Co Recent Developments
  31. 6.6 Gan & Lee
  32. 6.6.1 Gan & Lee Company Information
  33. 6.6.2 Gan & Lee Business Overview
  34. 6.6.3 Gan & Lee Long-acting Insulin Injection Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Gan & Lee Long-acting Insulin Injection Product Portfolio
  36. 6.6.5 Gan & Lee Recent Developments
  37. 6.7 Wockhardt
  38. 6.7.1 Wockhardt Company Information
  39. 6.7.2 Wockhardt Business Overview
  40. 6.7.3 Wockhardt Long-acting Insulin Injection Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Wockhardt Long-acting Insulin Injection Product Portfolio
  42. 6.7.5 Wockhardt Recent Developments
  43. 6.8 Viatris
  44. 6.8.1 Viatris Company Information
  45. 6.8.2 Viatris Business Overview
  46. 6.8.3 Viatris Long-acting Insulin Injection Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Viatris Long-acting Insulin Injection Product Portfolio
  48. 6.8.5 Viatris Recent Developments
  49. 6.9 Swixx Biopharma
  50. 6.9.1 Swixx Biopharma Company Information
  51. 6.9.2 Swixx Biopharma Business Overview
  52. 6.9.3 Swixx Biopharma Long-acting Insulin Injection Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Swixx Biopharma Long-acting Insulin Injection Product Portfolio
  54. 6.9.5 Swixx Biopharma Recent Developments
  55. 6.10 Lupin Laboratories
  56. 6.10.1 Lupin Laboratories Company Information
  57. 6.10.2 Lupin Laboratories Business Overview
  58. 6.10.3 Lupin Laboratories Long-acting Insulin Injection Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Lupin Laboratories Long-acting Insulin Injection Product Portfolio
  60. 6.10.5 Lupin Laboratories Recent Developments
  61. 6.11 KALBE PHARMA
  62. 6.11.1 KALBE PHARMA Company Information
  63. 6.11.2 KALBE PHARMA Business Overview
  64. 6.11.3 KALBE PHARMA Long-acting Insulin Injection Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 KALBE PHARMA Long-acting Insulin Injection Product Portfolio
  66. 6.11.5 KALBE PHARMA Recent Developments
  67. 6.12 INFION PHARMA
  68. 6.12.1 INFION PHARMA Company Information
  69. 6.12.2 INFION PHARMA Business Overview
  70. 6.12.3 INFION PHARMA Long-acting Insulin Injection Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 INFION PHARMA Long-acting Insulin Injection Product Portfolio
  72. 6.12.5 INFION PHARMA Recent Developments
  73. 6.13 Cipla
  74. 6.13.1 Cipla Company Information
  75. 6.13.2 Cipla Business Overview
  76. 6.13.3 Cipla Long-acting Insulin Injection Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Cipla Long-acting Insulin Injection Product Portfolio
  78. 6.13.5 Cipla Recent Developments
  79. 6.14 Biocon Biologics
  80. 6.14.1 Biocon Biologics Company Information
  81. 6.14.2 Biocon Biologics Business Overview
  82. 6.14.3 Biocon Biologics Long-acting Insulin Injection Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Biocon Biologics Long-acting Insulin Injection Product Portfolio
  84. 6.14.5 Biocon Biologics Recent Developments
  85. 6.15 Biocare
  86. 6.15.1 Biocare Company Information
  87. 6.15.2 Biocare Business Overview
  88. 6.15.3 Biocare Long-acting Insulin Injection Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Biocare Long-acting Insulin Injection Product Portfolio
  90. 6.15.5 Biocare Recent Developments
  91. 6.16 Abbott Laboratories
  92. 6.16.1 Abbott Laboratories Company Information
  93. 6.16.2 Abbott Laboratories Business Overview
  94. 6.16.3 Abbott Laboratories Long-acting Insulin Injection Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Abbott Laboratories Long-acting Insulin Injection Product Portfolio
  96. 6.16.5 Abbott Laboratories Recent Developments
7 North America by Country
  1. 7.1 North America Long-acting Insulin Injection Sales by Country
  2. 7.1.1 North America Long-acting Insulin Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Long-acting Insulin Injection Sales by Country (2021-2026)
  4. 7.1.3 North America Long-acting Insulin Injection Sales Forecast by Country (2027-2032)
  5. 7.2 North America Long-acting Insulin Injection Market Size by Country
  6. 7.2.1 North America Long-acting Insulin Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Long-acting Insulin Injection Market Size by Country (2021-2026)
  8. 7.2.3 North America Long-acting Insulin Injection Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Long-acting Insulin Injection Sales by Country
  2. 8.1.1 Europe Long-acting Insulin Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Long-acting Insulin Injection Sales by Country (2021-2026)
  4. 8.1.3 Europe Long-acting Insulin Injection Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Long-acting Insulin Injection Market Size by Country
  6. 8.2.1 Europe Long-acting Insulin Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Long-acting Insulin Injection Market Size by Country (2021-2026)
  8. 8.2.3 Europe Long-acting Insulin Injection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Long-acting Insulin Injection Sales by Country
  2. 9.1.1 Asia-Pacific Long-acting Insulin Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Long-acting Insulin Injection Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Long-acting Insulin Injection Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Long-acting Insulin Injection Market Size by Country
  6. 9.2.1 Asia-Pacific Long-acting Insulin Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Long-acting Insulin Injection Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Long-acting Insulin Injection Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Long-acting Insulin Injection Sales by Country
  2. 10.1.1 South America Long-acting Insulin Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Long-acting Insulin Injection Sales by Country (2021-2026)
  4. 10.1.3 South America Long-acting Insulin Injection Sales Forecast by Country (2027-2032)
  5. 10.2 South America Long-acting Insulin Injection Market Size by Country
  6. 10.2.1 South America Long-acting Insulin Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Long-acting Insulin Injection Market Size by Country (2021-2026)
  8. 10.2.3 South America Long-acting Insulin Injection Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Long-acting Insulin Injection Sales by Country
  2. 11.1.1 Middle East and Africa Long-acting Insulin Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Long-acting Insulin Injection Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Long-acting Insulin Injection Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Long-acting Insulin Injection Market Size by Country
  6. 11.2.1 Middle East and Africa Long-acting Insulin Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Long-acting Insulin Injection Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Long-acting Insulin Injection Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Long-acting Insulin Injection Value Chain Analysis
  2. 12.1.1 Long-acting Insulin Injection Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Long-acting Insulin Injection Production Mode & Process
  7. 12.2 Long-acting Insulin Injection Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Long-acting Insulin Injection Distributors
  10. 12.2.3 Long-acting Insulin Injection Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst